Document Detail


Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid.
MedLine Citation:
PMID:  18289332     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To report the management and outcomes in patients with metastatic eyelid sebaceous cell carcinoma. METHODS: The clinical records of four patients with metastatic eyelid sebaceous cell carcinoma treated between January 1999 and August 2006 were reviewed. RESULTS: The study included four women with a mean age of 66 years. Metastatic sites included the lung in three patients, regional lymph nodes in two, liver in two, and bone in one. Time from diagnosis of eyelid carcinoma to metastasis ranged from 0 to 62 months. Treatment of regional nodal metastasis consisted of complete neck dissection followed by radiation therapy. One patient developed lung metastasis 5 years after the diagnosis of eyelid tumor; she was treated with systemic chemotherapy followed by subtotal lung resection. Systemic chemotherapy was considered for two additional patients: in one, chemotherapy was deferred due to poor performance status and ongoing medical problems; and another patient died before chemotherapy could be started. The patient with bony metastasis was treated with radiation therapy to the spine. Two patients died during the study period. The follow-up time from diagnosis of metastasis to last contact or death ranged from 1 month to 3 years (median of 21 months). CONCLUSION: Eyelid sebaceous cell carcinoma can result in systemic metastasis and death. Metastasis can be discovered as late as 5 years after treatment of the eyelid carcinoma, warranting continued surveillance. Treatment of metastatic disease may include a combination of chemotherapy, radiation, and surgical neck dissection.
Authors:
Amina Husain; George Blumenschein; Bita Esmaeli
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  International journal of dermatology     Volume:  47     ISSN:  1365-4632     ISO Abbreviation:  Int. J. Dermatol.     Publication Date:  2008 Mar 
Date Detail:
Created Date:  2008-02-21     Completed Date:  2008-03-20     Revised Date:  2009-03-05    
Medline Journal Info:
Nlm Unique ID:  0243704     Medline TA:  Int J Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  276-9     Citation Subset:  IM    
Affiliation:
Section of Ophthalmology, Department of Thoracic Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma, Sebaceous / diagnosis,  secondary*,  therapy
Aged
Aged, 80 and over
Bone Neoplasms / secondary*,  therapy
Carcinoma, Basal Cell / diagnosis
Chalazion / diagnosis
Diagnostic Errors
Eyelid Neoplasms / pathology*,  therapy
Female
Humans
Liver Neoplasms / secondary*
Lung Neoplasms / secondary*,  therapy
Lymphatic Metastasis / radiotherapy
Middle Aged
Parotid Neoplasms / secondary*,  therapy
Retrospective Studies
Sebaceous Gland Neoplasms / diagnosis,  pathology*,  therapy

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Intertriginous plasmacytosis with plasmoacanthoma: report of a typical case and review of the litera...
Next Document:  The effect of 50% glycolic acid on the percutaneous absorption of eutectic mixture of local anesthet...